Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Medivation Inc (NASDAQ:MDVN)

80.24
Delayed Data
As of Aug 25
 +0.01 / +0.01%
Today’s Change
26.41
Today|||52-Week Range
80.67
+65.99%
Year-to-Date
Portfolio Manager: Is Pfizer Acquiring Too Quickly?
Aug 24 / TheStreet.com - Paid Partner Content
Why Pfizer's Latest Deal Could Send Its Shares Soaring
Aug 24 / TheStreet.com - Paid Partner Content
Dear Pfizer, Stop Overpaying for Acquisitions!
Aug 24 / MotleyFool.com - Paid Partner Content
5 Things You Must Know Before the Market Opens Wednesday
Aug 24 / TheStreet.com - Paid Partner Content
Biotech Stock Roundup: Medivation to Pfizer, Clovis Priority Review
Aug 24 / Zacks.com - Paid Partner Content
Stock Market News for August 23, 2016
Aug 23 / Zacks.com - Paid Partner Content
Which Criteria Best Determine the Success of Mergers?
Aug 24 / GuruFocus News - Paid Partner Content
Medivation (MDVN) Stock Downgraded After Pfizer Deal
Aug 23 / TheStreet.com - Paid Partner Content
Market News Over Summer Vacation: PFE, AZN, TSLA, LZB
Aug 24 / Zacks.com - Paid Partner Content
What Pfizer Gets in Its $14 Billion Medivation Deal
Aug 23 / MotleyFool.com - Paid Partner Content

Today’s Trading

Previous close80.23
Today’s open80.24
Day’s range80.20 - 80.31
Volume8,163,074
Average volume (3 months)3,373,956
Market cap$13.3B
Dividend yield--
Data as of 4:00pm ET, 08/25/2016

Growth & Valuation

Earnings growth (last year)-15.48%
Earnings growth (this year)-213.56%
Earnings growth (next 5 years)+35.50%
Revenue growth (last year)+32.76%
P/E ratioNM
Price/Sales8.68
Price/Book15.07

Competitors

 Today’s
change
Today’s
% change
PRGOPerrigo Company PLC+0.63+0.72%
INCYIncyte Corp-2.34-2.84%
VRXValeant Pharmaceutic...+0.55+1.80%
BMRNBiomarin Pharmaceuti...-0.16-0.17%
Data as of 4:01pm ET, 08/25/2016

Financials

Next reporting dateNovember 3, 2016
EPS forecast (this quarter)$0.30
Annual revenue (last year)$943.3M
Annual profit (last year)$244.7M
Net profit margin25.94%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
David T. Hung
Chief Operating Officer
Marion McCourt
Corporate headquarters
San Francisco, California

Forecasts

Partner Offers

Search for Jobs